David D. Halbert's most recent trade in Caris Life Sciences Inc. - Ordinary Shares - Class A was a trade of 141,956 Common Stock done at an average price of $29.8 . Disclosure was reported to the exchange on Aug. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caris Life Sciences Inc. -... | David D. Halbert | Director, See Remarks, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.75 per share. | 11 Aug 2025 | 141,956 | 2,295,133 | - | 29.8 | 4,223,191 | Common Stock |
| Caris Life Sciences Inc. -... | David D. Halbert | Director, See Remarks, Ten Percent Owner | 25 Mar 2025 | 389,416,484 | 0 | - | - | Series A Preferred Stock | ||
| Caris Life Sciences Inc. -... | David D. Halbert | Director, See Remarks, Ten Percent Owner | 25 Mar 2025 | 104,761,535 | 121,025,002 | - | 0 | Common Stock | ||
| Caris Life Sciences Inc. -... | David D. Halbert | Director, See Remarks, Ten Percent Owner | 25 Mar 2025 | 29,629,630 | 0 | - | - | Series B Preferred Stock | ||
| Caris Life Sciences Inc. -... | David D. Halbert | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 413,839 | 2,437,089 | - | 0 | Common Stock | |
| Caris Life Sciences Inc. -... | David D. Halbert | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 360,750 | 2,023,250 | - | 0 | Common Stock |